Visualization of cGMP with cGi biosensors

Methods in Molecular Biology

Volumn 1020, Issue , 2013, Pages 89-120

  Thunemann, Martin ^a   Fomin, Natalie ^a   Krawutschke, Christian ^b   Russwurm, Michael ^b   Feil, Robert ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Adenovirus; Cell imaging; Cerebellum; Green fluorescent protein; Guanylyl cyclase; Intracellular signaling; Microscopy; Natriuretic peptide; Nitric oxide; Phosphodiesterase; Protein kinase G; Transgenic mice; VSMC

Indexed keywords

ADENOVIRUS VECTOR; CYCLIC GMP;

ANIMAL CELL; ARTICLE; BIOSENSOR; CALIBRATION; CELL ISOLATION; CONTROLLED STUDY; FLUORESCENCE RESONANCE ENERGY TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ADENOVIRIDAE; MURINAE; MUS MUSCULUS;

EID: 84881661858     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-459-3_6     Document Type: Article

References (48)

1. Beavo JA, Brunton LL (2002) Cyclic n ucleotide research-still expanding after half a century. Nat Rev Mol Cell Biol 3(9):710-718. doi: 10.1038/nrm911
2. Friebe A, Koesling D (2003) Regulation of nitric oxide-sensitive guanylyl cyclase. Circ Res 93(2):96-105. doi: 10.1161/01.RES. 0000082524.34487.31
3. Kuhn M (2003) Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. Circ Res 93(8):700-709. doi: 10.1161/01.RES.0000094745.28948.4D
4. Biel M, Michalakis S (2009) Cyclic nucleotidegated channels. Handb Exp Pharmacol 191:111-136. doi: 10.1007/978-3-540-68964-5-7
5. Hofmann F, Feil R, Kleppisch T et al (2006) Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol Rev 86(1):1-23. doi: 10.1152/physrev.00015.2005
6. Francis SH, Blount MA, Corbin JD (2011) Mammalian cyclic nucleotide phosphodiesterases: Molecular mechanisms and physiological functions. Physiol Rev 91(2):651-690. doi: 10.1152/physrev.00030.2010
7. Kleppisch T, Feil R (2009) cGMP signalling in the mammalian brain: Role in synaptic plasticity and behaviour. Handb Exp Pharmacol 191:549-579. doi: 10.1007/978-3-540-68964-5-24
8. Kemp-Harper B, Feil R (2008) Meeting report: CGMP matters. Sci Signal 1(9):pe12. doi: 10.1126/stke.19pe12
9. Menniti FS, Faraci WS, Schmidt CJ (2006) Phosphodiesterases in the CNS: Targets for drug development. Nat Rev Drug Discov 5(8):660-670. doi: 10.1038/nrd2058
10. Martel G, Hamet P, Tremblay J (2010) Central role of guanylyl cyclase in natriuretic peptide signaling in hypertension and metabolic syndrome. Mol Cell Biochem 334(1-2):53-65. doi: 10.1007/s11010-009-0326-8
11. Ehret GB, Munroe PB, Rice KM et al (2011) Genetic variants in novel pathways in fl uence blood pressure and cardiovascular disease risk. Nature 478(7367):103-109. doi: 10.1038/nature10405
12. Stasch JP, Becker EM, Alonso-Alija C et al (2001) NO-independent regulatory site on soluble guanylate cyclase. Nature 410(6825):212-215. doi: 10.1038/35065611
13. Stasch JP, Hobbs AJ (2009) NO-independent, haem-dependent soluble guanylate cyclase stimulators. Handb Exp Pharmacol 191:277-308. doi: 10.1007/978-3-540-68964-5-13
14. Stasch JP, Schmidt PM, Nedvetsky PI et al (2006) Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. J Clin Invest 116(9):2552-2561. doi: 10.1172/JCI28371
15. Schindler U, Strobel H, Schonafinger K et al (2006) Biochemistry and pharmacology of novel anthranilic acid derivatives activating heme-oxidized soluble guanylyl cyclase. Mol Pharmacol 69(4):1260-1268. doi: 10.1124/mol.105.018747
16. Schmidt HH, Schmidt PM, Stasch JP (2009) NO- and haem-independent soluble guanylate cyclase activators. Handb Exp Pharmacol 191:309-339. doi: 10.1007/978-3-540-68964-5-14
17. Sanofi-Aventis (2008-2009) Ef ficacy and safety study of Ataciguat versus placebo in patients with neuropathic pain (SERENEATI). In: ClinicalTrials.gov [Internet]. National Library of Medicine (US). http://clinicaltrials.gov/ct2/ show/NCT00799656 NLM Identifier: NCT00799656. Accessed 31 May 2012
18. Sanofi-Aventis (2007-2008) Ef ficacy and safety of HMR1766 in patients with fontaine stage II peripheral arterial disease (ACCELA). In: ClinicalTrials.gov [Internet]. National Library of Medicine (US). http://clinicaltrials.gov/ct2/show/NCT00443287 NLM Identifier: NCT00443287. Accessed 31 Mar 2012
19. Fukumura D, Kashiwagi S, Jain RK (2006) The role of nitric oxide in tumour progression. Nat Rev Cancer 6(7):521-534. doi: 10.1038/nrc1910
20. Kashiwagi S, Tsukada K, Xu L et al (2008) Perivascular nitric oxide gradients normalize tumor vasculature. Nat Med 14(3):255-257. doi: 10.1038/nm1730
21. Calabrese V, Mancuso C, Calvani M et al (2007) Nitric oxide in the central nervous system: Neuroprotection versus neurotoxicity. Nat Rev Neurosci 8(10):766-775. doi: 10.1038/nrn2214
22. Olshevskaya EV, Ermilov AN, Dizhoor AM (2002) Factors that affect regulation of cGMP synthesis in vertebrate photoreceptors and their genetic link to human retinal degeneration. Mol Cell Biochem 230(1-2):139-147. doi: 10.1023/A:1014248208584
23. Jaumann M, Dettling J, Gubelt M et al (2012) cGMP-Prkg1 signaling and Pde5 inhibition shelter cochlear hair cells and hearing function. Nat Med 18(2):252-259. doi: 10.1038/nm.2634
24. Fischmeister R, Castro LR, Abi-Gerges A et al (2006) Compartmentation of cyclic nucleotide signaling in the heart: The role of cyclic nucleotide phosphodiesterases. Circ Res 99(8): 816-828. doi: 10.1161/01.RES.0000246118. 98832.04
25. Castro LR, Verde I, Cooper DM et al (2006) Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes. Circulation 113(18):2221-2228. doi: 10.1161/CIRCULATIONAHA.105.599241
26. Piggott LA, Hassell KA, Berkova Z et al (2006) Natriuretic peptides and nitric oxide stimulate cGMP synthesis in different cellular compartments. J Gen Physiol 128(1):3-14. doi: 10.1085/jgp.200509403
27. Nikolaev VO, Lohse MJ (2009) Novel techniques for real-time monitoring of cGMP in living cells. Handb Exp Pharmacol 191:229-243. doi: 10.1007/978-3-540-68964-5-11
28. Förster T (1946) Energiewanderung und Fluoreszenz. Naturwissenschaften 33(6):166-175. doi: 10.1007/bf00585226
29. Zaccolo M., 2004 Use of chimeric fl uorescent proteins and fl uorescence resonance energy transfer to monitor cellular responses, Circ Res 94, 7 866-873.
30. Zaccolo M (2004) Use of chimeric fl uorescent proteins and fl uorescence resonance energy transfer to monitor cellular responses. Circ Res 94(7):866-873. doi: 10.1161/01.RES. 0000123825.83803.CD 30. Nausch LW, Ledoux J, Bonev AD et al (2008) Differential patterning of cGMP in vascular smooth muscle cells revealed by single GFP-linked biosensors. Proc Natl Acad Sci USA 105(1):365-370. doi: 10.1073/pnas.0710387105
31. Russwurm M, Mullershausen F, Friebe A et al (2007) Design of fl uorescence resonance energy transfer (FRET)-based cGMP indicators: A systematic approach. Biochem J 407(1):69-77. doi: 10.1042/BJ20070348
32. Niino Y, Hotta K, Oka K (2009) Simultaneous live cell imaging using dual FRET sensors with a single excitation light. PLoS One 4(6):e6036. doi: 10.1371/journal.pone.0006036
33. Niino Y, Hotta K, Oka K (2010) Blue fl uorescent cGMP sensor for multiparameter fl uorescence imaging. PLoS One 5(2):e9164. doi: 10.1371/journal.pone.0009164
34. Lemke EA, Schultz C (2011) Principles for designing fl uorescent sensors and reporters. Nat Chem Biol 7(8):480-483. doi: 10.1038/nchembio.620
35. Feil S, Valtcheva N, Feil R (2009) Inducible Cre mice. Methods Mol Biol 530:343-363. doi: 10.1007/978-1-59745-471-1-18
36. Gesellchen F, Stangherlin A, Surdo N et al (2011) Measuring spatiotemporal dynamics of cyclic AMP signaling in real-time using FRET-based biosensors. Methods Mol Biol 746:297-316. doi: 10.1007/978-1-61779-126-0-16
37. Rasband WS (1997-2012) ImageJ. U. S. National Institutes of Health, Bethesda, MD, USA. http://imagej.nih.gov/ij/
38. Kaech S, Banker G (2006) Culturing hippocampal neurons. Nat Protoc 1(5):2406-2415. doi: 10.1038/nprot.2006.356
39. Shelly M, Lim BK, Cancedda L et al (2010) Local and long-range reciprocal regulation of cAMP and cGMP in axon/dendrite formation. Science 327(5965):547-552. doi: 10.1126/science.1179735
40. von Hayn K, Werthmann RC, Nikolaev VO et al (2010) Gq-mediated Ca2+ signals inhibit adenylyl cyclases 5/6 in vascular smooth muscle cells. Am J Physiol Cell Physiol 298(2):C324-C332. doi: 10.1152/ajpcell.00197.2009
41. Zhang J, Chen L, Raina H et al (2010) In vivo assessment of artery smooth muscle [Ca2+]i and MLCK activation in FRET-based biosensor mice. Am J Physiol Heart Circ Physiol 299(3):H946-H956. doi: 10.1152/ajpheart.00359.2010
42. He TC, Zhou S, da Costa LT et al (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95(5):2509-2514
43. Luo J, Deng ZL, Luo X et al (2007) A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2(5):1236-1247. doi: 10.1038/nprot.2007.135
44. Brewer GJ, Torricelli JR, Evege EK et al (1993) Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serumfree medium combination. J Neurosci Res 35(5):567-576. doi: 10.1002/jnr.490350513
45. Griesbeck O, Baird GS, Campbell RE et al (2001) Reducing the environmental sensitivity of yellow fl uorescent protein. Mechanism and applications. J Biol Chem 276(31):29188-29194. doi: 10.1074/jbc.M102815200
46. Sato M, Hida N, Ozawa T et al (2000) Fluorescent indicators for cyclic GMP based on cyclic GMP-dependent protein kinase Ialpha and green fl uorescent proteins. Anal Chem 72(24):5918-5924. doi: 10.1021/ac0006167
47. Honda A, Adams SR, Sawyer CL et al (2001) Spatiotemporal dynamics of guanosine 3 ¢, 5 ¢ -cyclic monophosphate revealed by a genetically encoded, fl uorescent indicator. Proc Natl Acad Sci USA 98(5):2437-2442. doi: 10.1073/pnas.051631298
48. Nikolaev VO, Gambaryan S, Lohse MJ (2006) Fluorescent sensors for rapid monitoring of intracellular cGMP. Nat Methods 3(1):23-25. doi: 10.1038/nmeth816